This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Ge Healthcare Limited, Norsk Medisinsk Syklotronsenter as. Active years: 2013-2020.
Location History:
- Kjeller, NO (2013)
- Oslo, NO (2013 - 2020)
Company Filing History:
Years Active: 2013-2020
Title: Dag Erlend Olberg: Innovator in Radiopharmaceuticals
Introduction
Dag Erlend Olberg is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 3 patents. His work focuses on the synthesis of radiolabelling agents that are essential for medical imaging and diagnostics.
Latest Patents
Olberg's latest patents include innovative methods for synthesizing radiolabelling agents. These agents are crucial for labeling biomolecules used as radiopharmaceuticals. His inventions also encompass PET imaging methods and diagnostic techniques that utilize these radiolabelling agents. Another significant patent involves reagents and methods for [F]-fluorination of biomolecules, particularly peptides. The resulting F-labelled compounds are valuable for use in Positron Emission Tomography (PET).
Career Highlights
Throughout his career, Dag Erlend Olberg has worked with prominent companies in the healthcare sector, including GE Healthcare Limited and Norsk Medisinsk Syklotronsenter AS. His expertise in radiopharmaceuticals has positioned him as a key figure in the development of advanced medical imaging technologies.
Collaborations
Olberg has collaborated with various professionals in his field, including Anders Svadberg and Joseph Maduabuchi Arukwe. These collaborations have further enhanced his research and development efforts in radiopharmaceuticals.
Conclusion
Dag Erlend Olberg's contributions to the field of radiopharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact medical imaging and diagnostics significantly.